Clinical Trials Browser

OTHER_GOV × apatinib × Thoracic × Clear all

NCT06786312 2025-01-22

A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer

Phase 2 Not yet recruiting

Small Cell Lung Carcinoma

NCT04901754 2021-12-08

CAMERA

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT03389087 2020-07-10

Study of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer

Phase 2 Unknown

Small Cell Lung Carcinoma

NCT02980809 2016-12-02

Topotecan Plus Apatinib Versus Topotecan Alone as Second-line Therapy in Small-cell Lung Cancer

Phase 2 Unknown

Small Cell Lung Carcinoma